DaShenLin Pharmaceutical Group Co., Ltd. (SHA: 603233)

China flag China · Delayed Price · Currency is CNY
17.30
+0.65 (3.90%)
Nov 12, 2024, 3:00 PM CST
-31.89%
Market Cap 19.70B
Revenue (ttm) 26.54B
Net Income (ttm) 850.26M
Shares Out 1.14B
EPS (ttm) 0.75
PE Ratio 23.10
Forward PE 20.05
Dividend 0.62 (3.72%)
Ex-Dividend Date Oct 23, 2024
Volume 31,552,393
Open 16.65
Previous Close 16.65
Day's Range 16.65 - 17.55
52-Week Range 11.92 - 27.10
Beta 0.30
Analysts n/a
Price Target n/a
Earnings Date Oct 29, 2024

About DaShenLin Pharmaceutical Group

DaShenLin Pharmaceutical Group Co., Ltd. manufactures, wholesales, and retails pharmaceutical products in China. It provides Chinese and western patent medicines, ginseng tonic medicinal materials and Chinese herbal pieces, health care products, medical equipment, and other commodities. The company was incorporated in 1999 and is based in Guangzhou, China. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1999
Employees 45,466
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603233
Full Company Profile

Financial Performance

In 2023, DaShenLin Pharmaceutical Group's revenue was 24.53 billion, an increase of 15.45% compared to the previous year's 21.25 billion. Earnings were 1.17 billion, an increase of 12.63%.

Financial Statements

News

There is no news available yet.